DUBLIN, Ireland–(EMWNews)–Research and Markets (http://www.researchandmarkets.com/research/9cf987/novartis_partnerin)

has announced the addition of the “Novartis Partnering Guide 2008”

company profile to their offering.

This report provides all the information you require to better

understand Novartis and its partnering interests and activities over the

past five years.

One of the key aspects of partnering is finding those companies that are

potential partners for the development and commercialization of the next

generation of therapies as developed by innovative biopharma R&D

companies. A lot of resources are spent on finding partners, identifying

their interests and making contact to initiate discussions.

Using this report, dealmakers will effectively and efficiently determine

the suitability of Novartis as a prospective partner, their business

development objectives, interests and recent partnering activity, key

partnering contacts, and partnering contract documents signed with their

recent partners.

The report provides a firm basis for initial due diligence into Novartis

as a prospective partner company.

The initial chapters of this report provide an orientation of bigpharma’s

dealmaking and business activities.

Key benefits

– Detailed company profile of the company

– In-depth marketed and pipeline product activity for the company

– Partnering interests and therapy focus revealed

– Partnering activity since 2000 – number of

deals per year

– Partnering activity for 2005-2008

– Activity by deal type

– Activity by phase of development

– Activity by therapeutic area

– List of recent partner companies

– Comprehensive access to actual contracts entered into by the company

and its partners*

– Insight into the terms included in a partnering agreement

– Understand the key deal terms the company has agreed in previous deals

– Undertake due diligence to assess suitability of your proposed deal

terms for partner companies

*Subject to being published via regulatory requirements of the

Securities Exchange Commission.

Report scope

Novartis Partnering Guide 2008 is intended to provide the reader with an

in-depth understanding of the partnering activities and interests of the

company, enabling the effective assessment and selection of partners of

choice, based on the latest knowledge of a company’s

approach to partnering.

Novartis Partnering Guide 2008 includes:

Detailed company profile including:

– Full contact details

– Business developer contact details including name, title, email and

telephone (where available)

– Marketed indications

– Pipeline indications

– Partnering interests and indications

– Partnering activity since 2000

– Current partner companies since 2005

– Partnering activity since 2005 by:

– Deal type

– Stage of development

– Therapy area

– Numerous charts showing the dealmaking activity of the company since

2005

– The tools to enable effective and efficient preparation for partnering

negotiation with the company

– Listing of contract documents between the company and its partners

– The leading M&A and partnering deals by value 2005-8

– Most active M&A and partnering dealmakers 2005-8

Key Topics Covered:

Chapter 1 – Introduction

Chapter 2 – Bigpharma –

The Top 50

Chapter 3 – Most active bigpharma dealmakers

Chapter 4 – Top bigpharma deals –

2000-7

Chapter 5 – Submitting Opportunities to

Bigpharma such as Novartis

Chapter 6 – Forthcoming bigpharma partnering

events

Chapter 7 – Novartis –

therapy locator

Chapter 8 – Bigpharma Company Profiles

For more information visit http://www.researchandmarkets.com/research/9cf987/novartis_partnerin

Major Newsire & Press Release Distribution with Basic Starting at only $19 and Complete OTCBB / Financial Distribution only $89

Get Unlimited Organic Website Traffic to your Website 
TheNFG.com now offers Organic Lead Generation & Traffic Solutions